Xeris Pharma down 9% premarket on stock offering

|About: Xeris Pharmaceuticals,... (XERS)|By:, SA News Editor

Thinly traded micro cap Xeris Pharmaceuticals (NASDAQ:XERS) slips 9% premarket on increased volume in reaction to its planned public offering of ~1M common shares (down from 5M) at $10 per share.

Yesterday's close was $10.54.

Subscribe for full text news in your inbox